NFATc1/αA: The other Face of NFAT Factors in Lymphocytes

[1]  F. Berberich-Siebelt,et al.  NFATc1/αA: The other Face of NFAT Factors in Lymphocytes , 2012, Cell Communication and Signaling.

[2]  A. Waisman,et al.  The dependence on NFAT levelsdiscriminates conventional T cells from Foxp3+ regulatory T cells , 2012 .

[3]  Wei Lu,et al.  The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease , 2011, Nature Immunology.

[4]  Sonia Sharma,et al.  Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex , 2011, Proceedings of the National Academy of Sciences.

[5]  J. Stroud,et al.  Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells. , 2011, Immunity.

[6]  A. Rosenwald,et al.  NFATc1 affects mouse splenic B cell function by controlling the calcineurin–NFAT signaling network , 2011, The Journal of experimental medicine.

[7]  Anjana Rao,et al.  Interaction of calcineurin with substrates and targeting proteins. , 2011, Trends in cell biology.

[8]  T. Sparwasser,et al.  Regulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1) , 2011, Proceedings of the National Academy of Sciences.

[9]  C. Bueso-Ramos,et al.  An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas. , 2010, Blood.

[10]  G. Crabtree,et al.  Identification of a putative regulator of early T cell activation genes. Science. 1988. 241: 202-205. , 2010, Journal of immunology.

[11]  T. Mikkelsen,et al.  The NIH Roadmap Epigenomics Mapping Consortium , 2010, Nature Biotechnology.

[12]  Anjana Rao,et al.  NFAT, immunity and cancer: a transcription factor comes of age , 2010, Nature Reviews Immunology.

[13]  R. Nurieva,et al.  The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation. , 2010, Immunity.

[14]  P. Hogan,et al.  Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. , 2010, Annual review of immunology.

[15]  T. Gress,et al.  NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells. , 2010, Gastroenterology.

[16]  A. Toker,et al.  NFAT proteins: emerging roles in cancer progression , 2009, Nature Reviews Cancer.

[17]  H. Ochs,et al.  FOXP3 Inhibits Activation-Induced NFAT2 Expression in T Cells Thereby Limiting Effector Cytokine Expression1 , 2009, The Journal of Immunology.

[18]  M. Buttmann,et al.  Sumoylation of the Transcription Factor NFATc1 Leads to Its Subnuclear Relocalization and Interleukin-2 Repression by Histone Deacetylase* , 2009, Journal of Biological Chemistry.

[19]  A. Rao,et al.  Transcriptional complexes formed by NFAT dimers regulate the induction of T cell tolerance , 2009, The Journal of experimental medicine.

[20]  J. Redondo,et al.  A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants. , 2009, Molecular cell.

[21]  Yuka Kanno,et al.  Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. , 2009, Immunity.

[22]  A. Beck‐Sickinger,et al.  Cell Communication and Signaling , 2009 .

[23]  T. Timmusk,et al.  Alternative splicing and expression of human and mouse NFAT genes☆ , 2008, Genomics.

[24]  I. Ho,et al.  A T-cell-specific CD154 transcriptional enhancer located just upstream of the promoter , 2008, Genes and Immunity.

[25]  J. Viola,et al.  Dual Roles for NFAT Transcription Factor Genes as Oncogenes and Tumor Suppressors , 2008, Molecular and Cellular Biology.

[26]  K. Schulze-Osthoff,et al.  Up-regulation of c-FLIP short by NFAT contributes to apoptosis resistance of short-term activated T cells. , 2008, Blood.

[27]  T. Hubbard,et al.  Large-Scale Mutagenesis in p19ARF- and p53-Deficient Mice Identifies Cancer Genes and Their Collaborative Networks , 2008, Cell.

[28]  T. Sumpter,et al.  Regulation of the NFAT pathway discriminates CD4+CD25+ regulatory T cells from CD4+CD25− helper T cells , 2008, Journal of leukocyte biology.

[29]  K. Furuuchi,et al.  Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer , 2008, Nature Immunology.

[30]  H. Müller-Hermelink,et al.  Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor signaling. , 2008, The American journal of pathology.

[31]  Andreas Radbruch,et al.  Inhibition of calcineurin‐NFAT signaling by the pyrazolopyrimidine compound NCI3 , 2007, European journal of immunology.

[32]  S. Feske.  Calcium signalling in lymphocyte activation and disease , 2007, Nature Reviews Immunology.

[33]  R. Locksley,et al.  A Costimulation-Initiated Signaling Pathway Regulates NFATc1 Transcription in T Lymphocytes1 , 2007, The Journal of Immunology.

[34]  G. Crabtree,et al.  Selective Role of NFATc3 in Positive Selection of Thymocytes1 , 2007, The Journal of Immunology.

[35]  H. Schild,et al.  Cyclic adenosine monophosphate is a key component of regulatory T cell–mediated suppression , 2007, The Journal of experimental medicine.

[36]  E. Serfling,et al.  NFAT transcription factors in control of peripheral T cell tolerance , 2006, European journal of immunology.

[37]  T. Höfer,et al.  NFATc1 autoregulation: a crucial step for cell-fate determination. , 2006, Trends in immunology.

[38]  T. Gress,et al.  Overexpression of c‐myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway , 2006, The EMBO journal.

[39]  A. Rao,et al.  Involvement of NFAT1 in B Cell Self-Tolerance1 , 2006, The Journal of Immunology.

[40]  F. Powrie,et al.  Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation , 2006, Immunological reviews.

[41]  J. Stroud,et al.  FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT , 2006, Cell.

[42]  S. Ziegler.  FOXP3: of mice and men. , 2006, Annual review of immunology.

[43]  L. Klein,et al.  A central role for central tolerance. , 2006, Annual review of immunology.

[44]  M. Wabl,et al.  A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus. , 2005, Blood.

[45]  S. Batalov,et al.  A Strategy for Probing the Function of Noncoding RNAs Finds a Repressor of NFAT , 2005, Science.

[46]  T. Wirth,et al.  B Cell Hyperresponsiveness and Expansion of Mature Follicular B Cells but Not of Marginal Zone B Cells in NFATc2/c3 Double-Deficient Mice1 , 2005, The Journal of Immunology.

[47]  A. Rudensky,et al.  A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 , 2005, Nature Immunology.

[48]  H. Schild,et al.  NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells , 2005, The Journal of experimental medicine.

[49]  Junying Yuan,et al.  Dual Role of Sumoylation in the Nuclear Localization and Transcriptional Activation of NFAT1* , 2004, Journal of Biological Chemistry.

[50]  Mithilesh Kumar Jha,et al.  NFAT and NF-κB factors—the distant relatives , 2004 .

[51]  Y. Ben-Neriah,et al.  Behind the scenes of anergy: a tale of three E3s , 2004, Nature Immunology.

[52]  Michael Loran Dustin,et al.  Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins , 2004, Nature Immunology.

[53]  P. Pagel,et al.  NFAT and NF-kappaB factors-the distant relatives. , 2004, The international journal of biochemistry & cell biology.

[54]  H. Boehmer,et al.  Thymus and autoimmunity , 2003 .

[55]  R. Berland,et al.  Normal B-1a cell development requires B cell-intrinsic NFATc1 activity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[56]  S. Harrison,et al.  An asymmetric NFAT1 dimer on a pseudo-palindromic κB-like DNA site , 2003, Nature Structural Biology.

[57]  Lin Chen,et al.  Transcriptional regulation by calcium, calcineurin, and NFAT. , 2003, Genes & development.

[58]  Akira Harashima,et al.  NF‐ATc2 induces apoptosis in Burkitt's lymphoma cells through signaling via the B cell antigen receptor , 2003, European journal of immunology.

[59]  S. Harrison,et al.  An asymmetric NFAT1 dimer on a pseudo-palindromic kappa B-like DNA site. , 2003, Nature structural biology.

[60]  J. Stroud,et al.  Structure of NFAT1 bound as a dimer to the HIV-1 LTR kappa B element. , 2003, Nature structural biology.

[61]  T. Nakayama,et al.  T Cell Hyporesponsiveness Induced by Oral Administration of Ovalbumin Is Associated with Impaired NFAT Nuclear Translocation and p27kip1 Degradation , 2002, The Journal of Immunology.

[62]  Takeshi Suzuki,et al.  New genes involved in cancer identified by retroviral tagging , 2002, Nature Genetics.

[63]  Anjana Rao,et al.  Transcriptional Mechanisms Underlying Lymphocyte Tolerance , 2002, Cell.

[64]  F. Berberich-Siebelt,et al.  Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. , 2002, Immunity.

[65]  G. Crabtree,et al.  NFAT Signaling Choreographing the Social Lives of Cells , 2002, Cell.

[66]  P. Robson,et al.  Regulation of the Murine Nfatc1 Gene by NFATc2* , 2002, The Journal of Biological Chemistry.

[67]  L. Glimcher,et al.  NFATc2 and NFATc3 regulate TH2 differentiation and modulate TCR-responsiveness of naïve TH cells , 2002, Nature Immunology.

[68]  A. Rudensky,et al.  Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo , 2002, Nature Immunology.

[69]  F. Berberich-Siebelt,et al.  The role of NF-AT transcription factors in T cell activation and differentiation. , 2000, Biochimica et biophysica acta.

[70]  J. Qin,et al.  Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. , 2000, Molecular cell.

[71]  L. Glimcher,et al.  Sequential involvement of NFAT and Egr transcription factors in FasL regulation. , 2000, Immunity.

[72]  M. Justice,et al.  Genetic profile of insertion mutations in mouse leukemias and lymphomas. , 2000, Genome research.

[73]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[74]  M. Glimcher,et al.  The Nuclear Factor of Activated T Cells (Nfat) Transcription Factor Nfatp (Nfatc2) Is a Repressor of Chondrogenesis , 2000, The Journal of experimental medicine.

[75]  S. Ju,et al.  FasL promoter activation by IL‐2 through SP1 and NFAT but not Egr‐2 and Egr‐3 , 1999, European journal of immunology.

[76]  P. Krammer,et al.  Novel Egr/NF‐AT composite sites mediate activation of the CD95 (APO‐1/Fas) ligand promoter in response to T cell stimulation , 1999, European journal of immunology.

[77]  A. Rao,et al.  NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[78]  A. Kerstan,et al.  Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes. , 1999, Journal of immunology.

[79]  Andrew J. Bannister,et al.  CBP/p300 integrates Raf/Rac-signaling pathways in the transcriptional induction of NF-ATc during T cell activation. , 1999, Immunity.

[80]  A. Kerstan,et al.  Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. , 1999, Immunity.

[81]  L. Glimcher,et al.  Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. , 1998, Immunity.

[82]  E. Serfling,et al.  The Interleukin 2 Receptor α Chain/CD25 Promoter Is a Target for Nuclear Factor of Activated T Cells , 1998, The Journal of experimental medicine.

[83]  L. Glimcher,et al.  The transcription factor NFAT4 is involved in the generation and survival of T cells. , 1998, Immunity.

[84]  Tak W. Mak,et al.  Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum , 1998, Nature.

[85]  Michael J. Grusby,et al.  The transcription factor NF-ATc is essential for cardiac valve formation , 1998, Nature.

[86]  F. Alt,et al.  Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. , 1998, Immunity.

[87]  G. Crabtree,et al.  The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. , 1998, Immunity.

[88]  S. Eliason,et al.  Two NFAT Transcription Factor Binding Sites Participate in the Regulation of CD95 (Fas) Ligand Expression in Activated Human T Cells* , 1997, The Journal of Biological Chemistry.

[89]  G. Edwalds-Gilbert,et al.  Alternative poly(A) site selection in complex transcription units: means to an end? , 1997, Nucleic acids research.

[90]  E. Serfling,et al.  NF-ATp plays a prominent role in the transcriptional induction of Th2-type lymphokines. , 1997, Immunology letters.

[91]  G. Crabtree,et al.  Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. , 1997, Immunity.

[92]  A. Rao,et al.  Mechanisms of transactivation by nuclear factor of activated T cells-1 , 1996, The Journal of experimental medicine.

[93]  Anjana Rao,et al.  An Enhanced Immune Response in Mice Lacking the Transcription Factor NFAT1 , 1996, Science.

[94]  L. Glimcher,et al.  Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. , 1996, Immunity.

[95]  C Benoist,et al.  T helper cell subsets in insulin-dependent diabetes. , 1995, Science.

[96]  D. Lewis,et al.  The Human gp39 Promoter TWO DISTINCT NUCLEAR FACTORS OF ACTIVATED T CELL PROTEIN-BINDING ELEMENTS CONTRIBUTE INDEPENDENTLY TO TRANSCRIPTIONAL ACTIVATION* , 1995 .

[97]  R. Schwartz.  T cell anergy. , 2003, Annual review of immunology.

[98]  A. Rao,et al.  A T cell nuclear factor resembling NF-AT binds to an NF-kappa B site and to the conserved lymphokine promoter sequence "cytokine-1". , 1992, The Journal of biological chemistry.

[99]  M. Karin,et al.  Ubiquitous and lymphocyte‐specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. , 1989, The EMBO journal.

[100]  G. Crabtree,et al.  Identification of a putative regulator of early T cell activation genes. , 1988, Science.

[101]  S. Sakaguchi,et al.  Thymus and autoimmunity. Transplantation of the thymus from cyclosporin A-treated mice causes organ-specific autoimmune disease in athymic nude mice , 1988, The Journal of experimental medicine.